EUVIMEDEUVIMED entdecken
Crossref

Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss

Dolvy Girawan

The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy · 30.04.2026 · 27 (1) · 1-2

DOI: 10.24871/27120261-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, online erschienen am 30.04.2026. Verfasst von Dolvy Girawan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

-

Zitieren

APA

Girawan, D. (2026). Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 27(1), 1-2. https://doi.org/10.24871/27120261-2

Vancouver

Girawan D. Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2026;27(1):1-2. doi:10.24871/27120261-2

BibTeX
@article{Girawan2026,
  author = {Girawan, Dolvy},
  title = {Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss},
  journal = {The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy},
  year = {2026},
  volume = {27},
  number = {1},
  pages = {1--2},
  doi = {10.24871/27120261-2}
}
Kostenlos starten →